









Markets
/
Stocks
/
nasdaq-evh
/

Evolent Health Inc

EVH

8.770USD

-0.180-2.01%

Close 09/29, 16:00（ET）Quotes delayed by 15 min

1.02BMarket Cap

LossP/E TTM



Evolent Health Inc

8.770

-0.180-2.01%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Evolent Health Inc

Currency: USD Updated: 2025-09-29

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Evolent Health Inc's Score

Industry at a Glance

Industry Ranking

36 / 207

Overall Ranking

122 / 4714

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 14 analysts

Buy

Current Rating

15.667

Target Price

+75.05%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Evolent Health Inc Highlights

StrengthsRisks

Evolent Health, Inc. is a health care company connecting care for people with complex conditions like cancer, cardiovascular disease, and musculoskeletal diagnoses. The Company offers three primary solutions: specialty care management services, total cost of care management and administrative services. It provides comprehensive quality management for oncology and cardiology patients from diagnosis through advance care planning services as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its total cost of care management solution enables providers to manage populations they may be accountable for under value-based contracts with payers or accountable care organizations (ACO) contracts with Centers for Medicare and Medicaid Services (CMS). Its administrative services solution includes integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 88.96% year-on-year.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 387.65.

Overvalued

The company’s latest PE is -5.46, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 129.14M shares, decreasing 9.64% quarter-over-quarter.

Held by Lee Ainslie

Star Investor Lee Ainslie holds 1.39M shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.77.

Financial Health

Currency: USD Updated: 2025-09-29

The company's current financial score is 7.51, which is higher than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 444.33M, representing a year-over-year decrease of 31.34%, while its net profit experienced a year-over-year decrease of 700.41%.

Score

Industry at a Glance

Previous score

7.51

Change



Financials

4.68

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

8.72

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

9.16

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

7.70

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.28

Key Metrics

Free cash flow

No Data

Evolent Health Inc's Company Valuation

Currency: USD Updated: 2025-09-29

The company’s current valuation score is 8.39, which is higher than the Healthcare Equipment & Supplies industry's average of 7.17. Its current P/E ratio is -5.46, which is -4.45% below the recent high of -5.22 and -183.08% above the recent low of -15.46.

Score

Industry at a Glance

Previous score

8.39

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 36/207

No Data

Earnings Forecast

Currency: USD Updated: 2025-09-29

The company’s current earnings forecast score is 8.43, which is higher than the Healthcare Equipment & Supplies industry's average of 7.70. The average price target for Evolent Health Inc is 15.50, with a high of 20.00 and a low of 9.00.

Score

Industry at a Glance

Previous score

8.43

Change

Support & Resistance

No Data

Analyst Rating

Based on 14 analysts

Buy

Current Rating

15.667

Target Price

+75.05%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Evolent Health Inc

EVH

Boston Scientific Corp

BSX

Edwards Lifesciences Corp

Intuitive Surgical Inc

ISRG

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-29

The company’s current price momentum score is 6.41, which is lower than the Healthcare Equipment & Supplies industry's average of 6.45. Sideways: Currently, the stock price is trading between the resistance level at 9.82 and the support level at 7.98, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.60

Change

-0.19

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(4)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

0.032

Neutral

RSI(14)

45.915

Neutral

STOCH(KDJ)(9,3,3)

44.946

Neutral

ATR(14)

0.498

Low Volatility

CCI(14)

-11.441

Neutral

Williams %R

70.878

Sell

TRIX(12,20)

-0.325

Sell

StochRSI(14)

43.534

Sell

Moving Average

Sell(5)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MA5

8.928

Sell

MA10

8.753

Buy

MA20

9.081

Sell

MA50

9.307

Sell

MA100

9.413

Sell

MA200

9.784

Sell

Institutional Confidence

Currency: USD Updated: 2025-09-29

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.89. The latest institutional shareholding proportion is 110.03%, representing a quarter-over-quarter decrease of 3.34%. The largest institutional shareholder is The Vanguard, holding a total of 10.90M shares, representing 9.28% of shares outstanding, with 3.97% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

10.92M

-1.76%

Cadian Capital Management LP

10.79M

+106.60%

BlackRock Institutional Trust Company, N.A.

7.78M

-3.05%

Morgan Stanley & Co. LLC

2.97M

+651.43%

Fidelity Management & Research Company LLC

3.21M

-28.36%

Engaged Capital, LLC

5.18M

-4.17%

William Blair Investment Management, LLC

4.40M

-7.89%

Eventide Asset Management, LLC

6.08M

+33.50%

State Street Global Advisors (US)

2.93M

-0.98%

Risk Assessment

Currency: USD Updated: 2025-09-29

The company’s current risk assessment score is 4.90, which is higher than the Healthcare Equipment & Supplies industry's average of 4.58. The company's beta value is 0.68. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.